Abstract | PURPOSE: To describe a unique presentation and treatment course of a patient with an established diagnosis of cone dystrophy. METHODS: Clinical examination, spectral domain optical coherence tomography, autofluorescence, fluorescein angiography, and electrophysiology testing were evaluated. RESULTS: A patient with cone dystrophy diagnosed by clinical examination and electrophysiology testing displayed a large amount of macular intraretinal and subretinal fluid on spectral domain optical coherence tomography in both eyes, without obvious angiographic leakage. Intraretinal fluid resolved after 7 weeks treatment on oral acetazolamide therapy. The patient had subjective improvement in peripheral vision, though the visual acuity remained the same. CONCLUSION:
|
Authors | Susan K Gelman, Michael B Gorin |
Journal | Retinal cases & brief reports
(Retin Cases Brief Rep)
Vol. 8
Issue 4
Pg. 300-5
( 2014)
ISSN: 1937-1578 [Electronic] United States |
PMID | 25372533
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Carbonic Anhydrase Inhibitors
- Acetazolamide
|
Topics |
- Acetazolamide
(therapeutic use)
- Administration, Oral
- Aged
- Carbonic Anhydrase Inhibitors
(therapeutic use)
- Humans
- Macular Edema
(drug therapy, etiology)
- Male
- Pedigree
- Retinitis Pigmentosa
(complications)
- Treatment Outcome
|